Table. 1.

Table. 1.

Demographics

Demographic C23 (gallbladder) (n = 44,178) C24 (extrahepatic bile duct) (n = 61,856) C25 (pancreas) (n = 101,487)
Age group (yr)
0–39 480 (1.1) 473 (0.8) 1,982 (2.0)
40–49 2,106 (4.8) 2,539 (4.1) 6,177 (6.1)
50–59 6,167 (14.0) 8,457 (13.7) 16,876 (16.6)
60–69 11,831 (26.8) 16,859 (27.3) 28,227 (27.8)
70–79 14,827 (33.6) 21,268 (34.4) 31,762 (31.3)
≥ 80 8,767 (19.8) 12,260 (19.8) 16,463 (16.2)
Sex
Male 18,973 (42.9) 35,327 (57.1) 55,003 (54.2)
Female 25,205 (57.1) 26,529 (42.9) 46,484 (45.8)
First course of treatment
Surgical 18,643 (42.2) 28,364 (45.9) 22,525 (22.2)
Non-surgical 5,842 (13.2) 4,425 (7.2) 27,820 (27.4)
No active or unknown treatment 19,693 (44.6) 29,067 (47.0) 51,142 (50.4)
SEER Stage (2006–2019)
Localized 6,109 (18.6) 12,371 (25.7) 9,091 (9.0)
Regional 11,248 (34.3) 20,538 (42.7) 24,167 (23.8)
Distant 11,768 (35.9) 5,954 (12.4) 34,510 (34.0)
Unstaged 3,661 (11.2) 9,233 (19.2) 33,719 (33.2)

Values are presented as number (%).

Ann Hepatobiliary Pancreat Surg 2022;26:220-8 https://doi.org/10.14701/ahbps.22-041
© 2022 Ann Hepatobiliary Pancreat Surg